Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Gains from Investment Securities: 2023

Historic Gains from Investment Securities for CG Oncology (CGON) over the last 1 years, with Dec 2023 value amounting to $221,000.

  • CG Oncology's Gains from Investment Securities rose 42850.00% to $859,000 in Q1 2025 from the same period last year, while for Sep 2024 it was $7.7 million, marking a year-over-year change of. This contributed to the annual value of $221,000 for FY2023, which is N/A change from last year.
  • As of FY2023, CG Oncology's Gains from Investment Securities stood at $221,000.
  • CG Oncology's Gains from Investment Securities' 5-year high stood at $221,000 during FY2023, with a 5-year trough of $221,000 in FY2023.
  • In the last 1 years, CG Oncology's Gains from Investment Securities had a median value of $221,000 in 2023 and averaged $221,000.